As of 11 Sept 2024, Immuno-Biological Laboratories net assets is $1.08B, an decrease of -21.17% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the Immuno-Biological Laboratories overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
Year | Net assets | Change |
---|---|---|
2023 | $1.08B | -21.17% |
2022 | $1.37B | -16.02% |
2021 | $1.63B | -16.38% |
2020 | $1.95B | 511.85% |
2019 | $318.45M | - |